in Newswire Published on September 27, 2023

Class Action Alleges Similasan Eye Drops Illegally Sold as Homeopathic Drugs Without FDA Approval [UPDATE]

by Corrado Rizzi

Last Updated on May 7, 2025

Plowden v. Similasan Corp.

Filed: September 26, 2023 § 1:23-cv-02511

A proposed class action alleges Similasan has illegally marketed its eye drops as homeopathic drugs capable of curing a range of ophthalmic conditions.

November 13, 2024 – Similasan Eye Drop Lawsuit Settled for $3.57 Million

Case Spotlight

Video Game Addiction Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

Last Updated on May 7, 2025 — 2:49 PM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Senior Managing Editor of ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.